European Society of Toxicology In Vitro > News > ESTIV and ONTOX signs Memorandum of Understanding
29 October 2021

ESTIV and ONTOX signs Memorandum of Understanding

Scope of Collaboration

ESTIV and ONTOX entered into the MoU to jointly conduct the following activities:

  • to share appropriate information related to the activities in the field of research on NAMs to adequate target audiences
  • to jointly organise events with clear mutual benefits for ESTIV and for ONTOX.

The MoU has been signed on 19 October 2021 by ESTIV President, Dr. Helena Kandarova and ONTOX Project Coordinator, Prof. Mathieu Vinken (VUB).


ONTOX is conducting a research project in the context of the European H2020 Research and Innovation Programme SC1-BHC-11-2020 called “Advancing the safety assessment of chemicals without the use of animal testing”. The vision of the ONTOX consortium is to provide a functional and sustainable solution for advancing human risk assessment of chemicals without the use of animals in line with the principles of 21st century toxicity testing and next generation risk assessment. More at: www.ontox-project.eu

Related content

Call for papers for the Special Virtual Issue ESTIV 2026!

The Toxicology in Vitro Special Issue linked to ESTIV 2026 brings together selected papers from the congress, highlighting cutting-edge research presented in Maastricht from 29 June to 2 July 2026. Aligned with the theme “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs.

Fraudulent e-mails offering ESTIV Congress attendance lists – be cautious!

Be aware that there are fraudulent e-mails sent out by scammers offering the congress attendance lists, accommodation, services etc

ESTIV Best Abstract Award at the VHP 2026 Conference

The award, valued at €300, will recognise an outstanding abstract in the field of in silico toxicology and New Approach Methodologies (NAMs).

Silver Sponsor

Communication partners

Memorandum of Understanding